Home Newsletters Mammary Cell News A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in...

A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer

0
Scientists investigated the activity of QBS10072S in vitro with various cell lines including the human TNBC cell line MDA-MB-231 and its brain-tropic derivative MDA-MB-231-BR3, where QBS10072S was found to be preferentially toxic to TNBC cells.
[Molecular Cancer therapeutics]

Sorry, but the selected Zotpress account can't be found.

AbstractGraphical Abstract
Exit mobile version